g&l's Profile
Displaying 51-100 of 2615 result(s).
Go to page:
Recent Articles
- Aarhus City Chooses cBrain F2 as a Digital Solution
- Neurizon's Breakthrough: FDA Approves NUZ-001 for ALS Trials
- Implantica Enhances Global Compliance with MDSAP Audit Success
- NB Private Equity Partners Announces Successful Share Buyback
- Fluor Corporation Investors: Join the Class Action Lawsuit
- Falcon Oil & Gas Ltd. Reports Significant Shareholding News
- Ford Faces Mechanics Shortages Amid Economic Challenges
- Trogenix Secures $95M to Propel Innovative Cancer Therapies
- Harness Therapeutics Unveils New MISBA Duo Platform with OVI
- Neurizon Therapeutics Achieves Milestone with NUZ-001 Approval
- Trogenix Secures Major Investment to Advance Cancer Therapies
- Exploring the Future Growth of MEMS Microphones Market
- TCM Group A/S: Shareholder Update and Company Overview
- Exploring Stolt-Nielsen's New Bond Opportunities for Investors
- Diversified Energy Company PLC Successfully Completes Buyback
- Falcon Oil & Gas Ltd. Updates on Shareholdings and Growth
- Elis Communicates Share Buyback Activities from Late September
- OSB Group PLC Completes Significant Share Buyback Initiative
- Significant Shareholding Changes in Irish Continental Group
- Foresight Group Holdings Ltd: Share Buyback Details and Impact
- Sampo plc's Share Buyback Strategy: A Detailed Overview
- Detailed Overview of Jyske Bank's Share Repurchase Activities
- Navigating Bitcoin's Surge: Analysts' Predictions and Insights
- BlueNord Updates on Strong Production Growth in Q3 2025
- Celebrating Web3 at the Vibrant HTX DAO and TRON Afterparty
- Valneva Reports on Voting Rights and Shareholder Information
- OneMove Capital Calls for Action from Dye & Durham's Directors
- Taiwan's Response to U.S. Semiconductor Production Demands
- Investors Seek Guidance Amid Potential Misleading Reports for SLP
- Investor Alert: National Grid plc Securities Class Action Update
- PST Group AB Initiates Share Delisting from Nasdaq Vilnius
- EG 427's Breakthrough Fast Track Status for DNA Therapy Solution
- Fagron Secures Key Antitrust Approval for Strategic Acquisitions
- Nyxoah's Genio System: A Milestone for Sleep Apnea Therapy
- Banqup Group Announces Transition in Board Leadership
- Corbion's Share Buyback Program Progress Report 2025
- Revolutionizing Kidney Disease Management with AI Technology
- TGS Unveils Q3 2025 Results Presentation Details
- Inbank's Bond Offering Surpasses Expectations with High Demand
- Nyxoah Takes a Major Step with Genio System in U.S. Healthcare
- Euronext N.V. Advances Its Tender Offer for ATHEX Shares
- Euronext's Strategic Move: Voluntary Offer for ATHEX Shares
- Lerøy Seafood's Impressive Harvest Numbers for Q3 2025
- Prominent Legal Firm Investigates Claims Against Nutex Health
- Investigation of PubMatic by Faruqi & Faruqi, LLP: What You Need to Know
- CTO Realty Growth Faces Legal Investigation: What Investors Need to Know
- Investors Urged to Assess Claims Against Quanex Building Products
- Dogecoin's Surge: Is a Rally to 30 Cents Imminent?
- Tim Cook Honors Steve Jobs on Anniversary of His Passing
- MoonLake Immunotherapeutics Faces Investigation Over Stock Drop
